New Corporate Oncology Account with GenesisCare
Filed with ASX · · 2 pages · English
Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings CallStory so far
Earlier from ImpediMed
- 2022 Annual Report & Annual General Meeting Date
- Appendix 4C & Quarterly Activities Report - Jun-2022 Qtr
- ImpediMed CEO Announces Departure
- Lymphoedema Risk Factors Paper Published
- Appendix 4C & Quarterly Activities Report
Later from ImpediMed
- Appendix 4C & Quarterly Activities Report - Sep-22 Qtr
- AstraZeneca Further Extends Clinical Trial Contract
- ImpediMed Announces Management Reorganisation
- ImpediMed Announces Appointment of Managing Director and CEO
- New Version of NCCN Guidelines for Breast Cancer
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed